| Sugammadex Hypersensitivity Study (Study P06042) (NCT00988065) | Merck Sharp & Dohme LLC | 2009-09-06 |
| Pilot Study of Intra-Arterial Cisplatin With IV Thiosulfate in Patients With Lung Cancer or Lung Metastases (NCT01114958) | University of California, San Diego | 2009-09-03 |
| Study Evaluating Safety, Tolerability, And Action Of OAP-189 In Subjects With Type 2 Diabetes On Metformin (NCT00970593) | Pfizer | 2009-09-02 |
| Romidepsin and Erlotinib Hydrochloride in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer (NCT01302808) | University of Texas Southwestern Medical Center | 2009-09-01 |
| Study to Assess the Safety and Tolerability of a Single Administration of FOV2302 (Ecallantide) in Patients With Macular Edema Associated With Central Retinal Vein Occlusion (NCT00969293) | Fovea Pharmaceuticals SA | 2009-09-01 |
| Food Effect Study on the Bioavailability and PK of PA-824 Tablets in Healthy Adult Subjects (CL-009) (NCT01830439) | Global Alliance for TB Drug Development | 2009-09-01 |
| Patterned Functional Electrical Stimulation (FES) Ergometry of Arm and Shoulder in Individuals With Spinal Cord Injury (NCT01005615) | Hugo W. Moser Research Institute at Kennedy Krieger, Inc. | 2009-09-01 |
| Bioequivalence Study of Budesonide/Formoterol Easyhaler and Symbicort Turbohaler in Asthmatics (NCT00964535) | Orion Corporation, Orion Pharma | 2009-09-01 |
| Mesenchymal Stromal Cells (MSCs) for the Treatment of Graft Versus Host Disease (GVHD) (NCT01764100) | Ettore Biagi, MD | 2009-09-01 |
| GLPG0259 Multiple Ascending Dose and Methotrexate Drug-drug Interaction (DDI) in Healthy Subjects (NCT00989703) | Lakefront Biotherapeutics NV | 2009-09-01 |
| Pharmacokinetic Properties of Nevirapine Extended Release Tablets When Administered Orally in Healthy Male Volunteers (NCT02194218) | Boehringer Ingelheim | 2009-09-01 |
| Study to Examine the Effect of Coated Phenylephrine Suppositories on Anal Pressure in Healthy Subjects (NCT00972998) | RDD Pharma Ltd | 2009-09-01 |
| Safety and Pharmacokinetics of ELB353 in Healthy Men (NCT00977886) | Biotie Therapies Corp. | 2009-09-01 |
| Study of CoQ10 During One Cycle of Doxorubicin Treatment for Breast Cancer (NCT00976131) | Columbia University | 2009-09-01 |
| A Study of the Specificity and Sensitivity of 5-ALA Fluorescence in Malignant Brain Tumors (NCT00977795) | Endeavor Health | 2009-09-01 |
| Treatment With Lenalidomide, Bendamustine and Prednisone (RBP) in Patients With Relapsed or Refractory Multiple Myeloma (NCT01002703) | University of Leipzig | 2009-09-01 |
| Study of IMC-1121B in Patients With Advanced Solid Tumors (NCT01005355) | Eli Lilly and Company | 2009-09-01 |
| Cerebral Antibiotics Distribution After Acute Brain Injury (NCT01059890) | Poitiers University Hospital | 2009-09-01 |
| SPC3649 Multiple Dose Study in Healthy Volunteers (NCT00979927) | Santaris Pharma A/S | 2009-09-01 |
| Effects of Gastric Antral Botulinum Toxin Injections in Obese Subjects (NCT00976443) | Mayo Clinic | 2009-09-01 |
| Effectiveness of a Technology Assisted Behavioral Intervention in Assisting People With Major Depressive Disorder (NCT00719979) | Northwestern University | 2009-09-01 |
| A/H1N1 Immunogenicity and Safety in Infants, Children and Adolescents (NCT00976469) | Alachua Government Services, Inc. | 2009-09-01 |
| A Study of Hedgehog Pathway Inhibitor GDC-0449 in Patients With Locally Advanced or Metastatic Solid Tumors That Are Refractory to Standard Therapy or for Whom No Standard Therapy Exists (NCT00968981) | Genentech, Inc. | 2009-09-01 |
| Relative Bioavailability Study of Solifenacin Succinate Liquid Suspension (Fed and Fasting) Versus VESIcare Tablet (Fasting) in Healthy Volunteers (NCT01015040) | Astellas Pharma Inc | 2009-09-01 |
| A Study for Japanese Participants With Rheumatoid Arthritis (RA) (NCT01253226) | Eli Lilly and Company | 2009-09-01 |
| Dose Escalation, Safety and Pharmacokinetic Study of SAR103168 in Patients Refractory/ Relapsed Acute Leukemias or High-risk Myelodysplastic Syndromes (NCT00981240) | Sanofi | 2009-09-01 |
| VX-950-TiDP24-C133 - A Phase I Study Investigating the Interaction Between Telaprevir and Escitalopram (NCT00933894) | Tibotec BVBA | 2009-09-01 |
| Human Pharmacology Study (Keppra Dry Syrup Bioequivalence Study) (NCT00985348) | UCB Pharma | 2009-09-01 |
| Immunization With HIV-1 Peptides in Adjuvant for Treatment of Patients With Chronic HIV-infection (NCT01009762) | Gitte Kronborg | 2009-09-01 |
| Study to Assess Safety, Tolerability and Pharmacokinetics After Single Dose of AZD2516 to Japanese Healthy Subjects (NCT00972049) | AstraZeneca | 2009-09-01 |
| A Study of the Hedgehog Pathway Inhibitor GDC-0449 in Healthy Female Subjects of Non-Childbearing Potential (NCT00991718) | Genentech, Inc. | 2009-09-01 |
| Crossover Bioequivalence Study of Oxcarbazepine 600 mg Suspension Under Fasted Conditions (NCT01702623) | Roxane Laboratories | 2009-09-01 |
| A Pharmacokinetic and Glucodynamic Study of Subcutaneously Administered Insulin Analogs With rHuPH20 Compared to Insulin Analogs Alone (NCT00979875) | Halozyme Therapeutics | 2009-09-01 |
| Study to Evaluate the Effect of Multiple Doses of Rifampicin on the Multiple-dose Pharmacokinetics of Linagliptin in Healthy Volunteers (NCT02183584) | Boehringer Ingelheim | 2009-09-01 |
| Seneca Valley Virus-001 and Cyclophosphamide in Treating Young Patients With Relapsed or Refractory Neuroblastoma, Rhabdomyosarcoma, or Rare Tumors With Neuroendocrine Features (NCT01048892) | Children's Oncology Group | 2009-09-01 |
| Drug Interactions Between Voriconazole and Atazanavir Coadministered as Atazanavir/Ritonavir in Healthy Participants (NCT00833482) | Bristol-Myers Squibb | 2009-09-01 |
| Study of GC33 and Sorafenib in Combination in Advanced or Metastatic Liver Cancer (Hepatocellular Carcinoma) (NCT00976170) | Chugai Pharmaceutical | 2009-09-01 |
| Lenalidomide, Vorinostat and Dexamethasone in Relapsed Patients With Peripheral T-Cell Non-Hodgkin's Lymphoma (PTCL) (NCT00972842) | Arbeitsgemeinschaft medikamentoese Tumortherapie | 2009-09-01 |
| The Safety/Tolerability and Pharmacokinetics (PKs) of Naftopidil in Korean Healthy Male Volunteers (NCT00967772) | Dong-A ST Co., Ltd. | 2009-09-01 |
| Positron Emission Tomography/Computed Tomography (PET/CT) Imaging for Radiation Dosimetry, Plasma Pharmacokinetics, Biodistribution, Safety and Tolerability and Diagnostic Performance of BAY86-4367 in Patients With Prostate Cancer and Healthy Volunteers (NCT00975299) | Bayer | 2009-09-01 |
| A Dose Escalation Trial of Radiation Therapy (RT) for Hepatocellular Carcinoma (HCC) (NCT00960167) | National Taiwan University Hospital | 2009-09-01 |
| Panobinostat in Combination With Idarubicin and Cytarabine in Patients Aged 65 Years or Older With Newly Diagnosed Acute Myeloblastic Leukaemia (AML) (NCT00840346) | PETHEMA Foundation | 2009-09-01 |
| Safety and Efficacy of BFH772 in Psoriasis Patients (NCT00987870) | Novartis Pharmaceuticals | 2009-09-01 |
| A Pharmacokinetics (PK) Study in Lice Infested Children 6 Months to 3 Years of Age (NCT00988533) | Topaz Pharmaceuticals Inc | 2009-09-01 |
| Novel Interventions in HIV-1 Infection (NCT01130376) | Imperial College London | 2009-09-01 |
| Cross-over Study to Prove Bioequivalence Between Two Brands of Cefalexin Suspension (NCT01073540) | Bayer | 2009-09-01 |
| A Study of Vincristine, Escalating Doses of Irinotecan, Temozolomide and Bevacizumab (Vit-b) in Pediatric and Adolescent Patients With Recurrent or Refractory Solid Tumors of Non-hematopoietic Origin (NCT00993044) | Children's Hospital Los Angeles | 2009-09-01 |
| Safety and Efficacy of a Natural Health Product in Reducing Cholesterol and Triglyceride Levels. (NCT01028274) | Nordic Pharma, USA | 2009-09-01 |
| Safety and Efficacy of Inhaled OligoG CF-5/20 for the Treatment Cystic Fibrosis (NCT00970346) | AlgiPharma AS | 2009-09-01 |
| A Study to Assess the Effect of Safinamide on Levodopa Pharmacokinetics (NCT01026428) | Newron Pharmaceuticals SPA | 2009-09-01 |
| A Single-Dose Study in Normal Volunteers to Assess the Safety, Tolerability and Pharmacokinetics of STX107 (NCT00965432) | Seaside Therapeutics, Inc. | 2009-09-01 |
| Effect of Intensified Physical Activity for Patients With Stroke - a Combined Physical and Behavioural Approach (NCT01161329) | Uppsala University | 2009-09-01 |
| Study to Assess Cardiac Conduction of GSK1349572 (NCT00996021) | GlaxoSmithKline | 2009-09-01 |
| The Treatment of Lapatinib in Combination With Sorafenib in Patients With Advanced Refractory Solid Tumors (NCT00984425) | Istituto Clinico Humanitas | 2009-09-01 |
| Pharmacokinetic Study to Rectal and Sublingual Administration of Tacrolimus in Future Kidney Transplant Patients (NCT00987103) | Maastricht University Medical Center | 2009-09-01 |
| Evaluation of Pharmacokinetics, Safety and Tolerability of Single and Multiple Oral Doses of Neramexane Mesylate in Healthy Japanese Subjects (NCT00983099) | Merz Pharmaceuticals GmbH | 2009-09-01 |
| Rituximab, Bendamustine Hydrochloride, and Lenalidomide in Treating Patients With Aggressive B-Cell Lymphoma (NCT00987493) | Swiss Cancer Institute | 2009-09-01 |
| Study on the Effect of Mitomycin C 0.02% on the Corneal Endothelial After Photorefractive Keratectomy in Moderate Myopia (NCT00999973) | Shahid Beheshti University of Medical Sciences | 2009-09-01 |
| HAI Irinotecan + IV Bevacizumab, Bevacizumab & Oxaliplatin or Bevacizumab & Cetuximab in Advanced Cancers Metastatic to Liver (NCT00980239) | M.D. Anderson Cancer Center | 2009-09-01 |
| LEO 27847 - A Study in Healthy Male Subjects (NCT01007383) | LEO Pharma | 2009-09-01 |
| A Study To Evaluate The Safety, Tolerability, Pharmacokinetics, And Pharmacodynamics Of PF-03882845 In Healthy Volunteers (NCT00971802) | Pfizer | 2009-09-01 |
| Safety and Tolerability Study of the Monoclonal Antibody CT-011 in Patients With Chronic Hepatitis C Genotype I Infection (NCT00962936) | CureTech Ltd | 2009-09-01 |
| Human African Trypanosomiasis: First in Man Clinical Trial of a New Medicinal Product, the Fexinidazole (NCT00982904) | Drugs for Neglected Diseases | 2009-09-01 |
| Carboplatin and Etoposide Plus LBH589 for Small Cell Lung Cancer (NCT00958022) | Ahmad Tarhini | 2009-09-01 |
| A Study of V260 in Healthy Chinese Adults, Children and Infants (V260-028)(COMPLETED) (NCT00953056) | Merck Sharp & Dohme LLC | 2009-09-01 |
| Trial to Evaluate the Safety of Lovastatin in Individuals With Neurofibromatosis Type I (NF1) (NCT00352599) | University of California, Los Angeles | 2009-09-01 |
| Dose Escalation Radiotherapy With Modulation of Intensity and Integrated Boost (SIB-IMRT) in the Treatment of Glioblastomas in Adults (NCT01043536) | Centre Georges Francois Leclerc | 2009-09-01 |
| Rectal Microbicide Safety and Acceptability Trial of Topically Applied Tenofovir Compared With Oral Tablet (NCT00984971) | CONRAD | 2009-09-01 |
| A Study to Assess DV-601 in Subjects With Chronic Hepatitis B (NCT01023230) | Dynavax Technologies Corporation | 2009-09-01 |
| The Efficacy of Doxazosin for Cocaine Users (NCT00880997) | Baylor College of Medicine | 2009-09-01 |
| Comparison Study of a New Combination of 2 Marketed Medications (Esomeprazole and Naprosyn) Versus Naprosyn Alone (NCT00992381) | AstraZeneca | 2009-09-01 |
| The Effect of Tranexamic Acid on Postpartum Hemorrhage During and After Cesarean Delivery (NCT01085006) | Tehran University of Medical Sciences | 2009-09-01 |
| Crossover Bioequivalence Study of Oxcarbazepine 600 mg Suspension Under Fed Conditions (NCT01703468) | Roxane Laboratories | 2009-09-01 |
| Safety Study of a Liposomal Vaccine to Treat Malignant Melanoma (NCT01052142) | Lipotek Pty Ltd | 2009-09-01 |
| Pharmacokinetics, Pharmacodynamics, and Safety of Alogliptin in Children, Adolescents and Adults With Type 2 Diabetes Mellitus (NCT00957268) | Takeda | 2009-09-01 |
| Carfilzomib and Lenalidomide With Dexamethasone Combination in Newly Diagnosed, Previously Untreated Multiple Myeloma (NCT01029054) | University of Michigan Rogel Cancer Center | 2009-09-01 |
| Outcomes In Children With Developmental Delay And Deafness (NCT01256229) | Stanford University | 2009-09-01 |
| Isovolumetric and Isocaloric Preloads of Various Types of Milk on Food Intake, Subjective Appetite and Glycemic Response (NCT01025557) | University of Toronto | 2009-09-01 |
| Study to Investigate the Activity of AZD5122 When Given as a Single Dose to Healthy Male Subjects (NCT00984477) | AstraZeneca | 2009-09-01 |
| Cisplatin, Temozolomide, Abraxane, With Interleukin-2 and Interferon for Metastatic Melanoma (NCT00970996) | M.D. Anderson Cancer Center | 2009-09-01 |
| A Pharmacokinetic Study of Subcutaneous and Intravenous Rituximab in Participants With Follicular Lymphoma (NCT00930514) | Hoffmann-La Roche | 2009-09-01 |
| Study to Evaluate the Relative Abuse Potential of Almorexant in Recreational Drug Users (NCT01987739) | Midnight Pharma, LLC | 2009-09-01 |
| LIP-01 in Hypercholesterolemia (NCT00966225) | Afexa Life Sciences Inc | 2009-09-01 |
| Feasibility Study of SOL (S-1,Oral Leucovorin,and Oxaliplatin) for Colorectal Cancer in China (NCT01110941) | Shen Lin | 2009-09-01 |
| Veltuzumab and Milatuzumab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma (NCT00989586) | Beth Christian | 2009-09-01 |
| Pharmacokinetics, Effect of Food, Safety and Tolerability of a New Tablet Formulation of GSK1144814 in Healthy Subjects (NCT01090440) | GlaxoSmithKline | 2009-09-01 |
| Study of Lenalidomide in Combination With Sunitinib to Evaluate the Safety and Efficacy in Patients With Renal Cell Carcinoma (NCT00975806) | Celgene | 2009-09-01 |
| Oral Cyclosporine in Chronic Obstructive Pulmonary Disease (NCT00974142) | Michael Donahoe | 2009-09-01 |
| A Study of PRT-201 Administered After Arteriovenous Graft (AVG) Creation in Patients With Chronic Kidney Disease (NCT01001351) | Proteon Therapeutics | 2009-09-01 |
| Trial of TG4023 Combined With Flucytosine in Liver Tumors (NCT00978107) | Transgene | 2009-09-01 |
| Does Auricular Acupuncture Improve Tolerance to Electromyography (EMG) Testing? (NCT01017211) | Kessler Foundation | 2009-09-01 |
| Lenalidomide, Bendamustine and Rituximab as First-line Therapy for Patients Over 65 Years With Mantle Cell Lymphoma. (NCT00963534) | Lund University Hospital | 2009-09-01 |
| Therapeutic Vaccination for Patients With HPV16+ Cervical Intraepithelial Neoplasia (CIN2/3) (NCT00988559) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2009-09-01 |
| Microtransplantation With Decitabine and Cytarabine Improves Patient Outcomes in Myelodysplastic Syndromes (NCT01674985) | The Affiliated Hospital of the Chinese Academy of Military Medical Sciences | 2009-09-01 |
| Relative Bioavailability of BI 10773 Administered Twice Daily Compared BI 10773 Given Once Daily After Multiple Oral Doses in Healthy Male and Female Volunteers (NCT02782624) | Boehringer Ingelheim | 2009-09-01 |
| Immediate VS Delayed Cord Clamping on Newborns (NCT01029496) | Hainan Medical College | 2009-09-01 |
| A Double-Dose Safety Study of An Influenza Vaccine (Multimeric-001) Injected to Elderly Volunteers (NCT01010737) | BiondVax Pharmaceuticals ltd. | 2009-09-01 |
| LBH589 (Panobinostat) for the Treatment of Myelofibrosis (NCT01298934) | Ronald Hoffman | 2009-09-01 |
| The Maraviroc Central Nervous System (CNS) Study (NCT00982878) | Imperial College London | 2009-09-01 |
| Safety and Efficacy Study in Hepatitis C Patients With PHN121 (NCT01052090) | PhytoHealth Corporation | 2009-09-01 |